Our recent publication identified HMGA2 as a biomarker of enzalutamide resistance in PCa [8].There are several isoforms of HMGA2; however, the most studied are truncated HMGA2 and the full-length wild-type HMGA2 [9]. Here, HMGA2 is linked to posterior cortical atrophy.